Research programme: proline dehydrogenase inhibitors - Calithera BiosciencesAlternative Names: Proline oxidase inhibitors - Calithera
Latest Information Update: 27 Jul 2015
At a glance
- Originator Calithera Biosciences
- Class Small molecules
- Mechanism of Action Oxidoreductase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Breast cancer